Skip to content
CancerIndex

Loading the knowledge graph…

Zanubrutinib, Chidamide, and Rituximab Induction With or Without CHOP Versus R-CHOP in Newly Diagnosed Double-Expressor DLBCL — knowledge graph · CancerIndex